米卡芬净治疗尿念珠菌病：病例系列。
Treatment of candiduria with micafungin: A case series.
机构信息
Department of Medicine, McMaster University.
出版信息
Can J Infect Dis Med Microbiol. 2007 Mar;18(2):149-50. doi: 10.1155/2007/768734.
Abstract
There has been a gradual increase in the incidence of non-Candida albicans-related nosocomial infections. Candida glabrata urinary tract infections have increased in frequency, and treating these infections can be difficult because the organism may be resistant to fluconazole. A newer antifungal agent, micafungin, which belongs in the class of echinocandins, provides an alternative and effective therapy against C glabrata. The present report describes three cases of C glabrata-associated urinary tract infections successfully treated with micafungin. To the authors' knowledge, this is the first report of successful treatment of C glabrata and azole-resistant C albicans-associated urinary tract infection with an echinocandin.
摘要
非白念珠菌相关医院感染的发病率逐渐上升。光滑念珠菌尿路感染的发病率也有所增加，而且由于该病原体可能对氟康唑耐药，治疗这些感染可能具有挑战性。新型抗真菌药物米卡芬净属于棘白菌素类，为治疗光滑念珠菌提供了一种替代且有效的治疗方法。本报告描述了三例成功用米卡芬净治疗的光滑念珠菌相关尿路感染。据作者所知，这是首例成功用棘白菌素治疗光滑念珠菌和唑类耐药白念珠菌相关尿路感染的报告。
相似文献
1
Treatment of candiduria with micafungin: A case series.米卡芬净治疗尿念珠菌病：病例系列。
Can J Infect Dis Med Microbiol. 2007 Mar;18(2):149-50. doi: 10.1155/2007/768734.
2
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
3
Micafungin treatment and eradication of candiduria among hospitalized patients.米卡芬净治疗并根除住院患者念珠菌尿症
Int Urol Nephrol. 2016 Nov;48(11):1881-1885. doi: 10.1007/s11255-016-1410-0. Epub 2016 Sep 1.
4
Micafungin Is an Efficient Treatment of Multi Drug-Resistant Urosepsis: A Case Report.米卡芬净是多重耐药性泌尿道感染的有效治疗药物：病例报告
J Fungi (Basel). 2021 Sep 24;7(10):800. doi: 10.3390/jof7100800.
5
6
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.米卡芬净对315株耐氟康唑侵袭性念珠菌临床分离株的活性
J Clin Microbiol. 2006 Feb;44(2):324-6. doi: 10.1128/JCM.44.2.324-326.2006.
7
A case of Candida glabrata severe urinary sepsis successfully treated with micafungin.1例光滑念珠菌所致严重尿源性脓毒症经米卡芬净成功治疗
Med Mycol Case Rep. 2014 May 10;5:1-3. doi: 10.1016/j.mmcr.2014.04.003. eCollection 2014 Jul.
8
Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans.光滑念珠菌和白色念珠菌所致医院获得性念珠菌尿的危险因素。
Clin Infect Dis. 1999 Oct;29(4):926-8. doi: 10.1086/520460.
9
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).Sensititre YeastOne 棘白菌素药敏试验流行病学折点用于鉴定 FKS 突变的白念珠菌和光滑念珠菌的准确性：瑞士真菌感染网络（FUNGINOS）的十年全国调查。
Clin Microbiol Infect. 2018 Nov;24(11):1214.e1-1214.e4. doi: 10.1016/j.cmi.2018.05.012. Epub 2018 Jun 15.
10
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.棘白菌素类、两性霉素 B 和伏立康唑对氟康唑敏感和氟康唑耐药巴西光滑念珠菌分离株的活性。
Mem Inst Oswaldo Cruz. 2012 May;107(3):433-6. doi: 10.1590/s0074-02762012000300022.
引用本文的文献
1
A case of pyelonephritis and bacteremia caused by Candida glabrata in a patient on sodium glucose cotransporter 2 inhibitor, successfully treated with micafungin.一名使用钠葡萄糖协同转运蛋白2抑制剂的患者发生光滑念珠菌引起的肾盂肾炎和菌血症，用米卡芬净成功治疗。
J Pharm Health Care Sci. 2025 Aug 5;11(1):65. doi: 10.1186/s40780-025-00475-w.
2
Case Report: Micafungin for treating urinary infection: a clinical case in a premature neonate.病例报告：米卡芬净治疗泌尿道感染：一例早产儿临床病例
Front Pediatr. 2024 May 17;12:1397456. doi: 10.3389/fped.2024.1397456. eCollection 2024.
3
Unilateral renal fungus ball caused by .由……引起的单侧肾真菌球
Med Mycol Case Rep. 2024 Apr 14;44:100649. doi: 10.1016/j.mmcr.2024.100649. eCollection 2024 Jun.
4
A Rare Case of Urinary Tract Fungal Ball Leading to Fungemia and Bilateral Chorioretinitis.一例罕见的泌尿道真菌球导致真菌血症和双侧脉络膜视网膜炎病例。
Case Rep Urol. 2020 Sep 28;2020:8828289. doi: 10.1155/2020/8828289. eCollection 2020.
5
Candiduria; a review article with specific data from Iran.念珠菌尿症；一篇来自伊朗的具有特定数据的综述文章。
Turk J Urol. 2018 Nov;44(6):445-452. doi: 10.5152/tud.2018.54069.
6
: A Unique Cause of Necrotizing Urethritis.坏死性尿道炎的一种独特病因。
Case Rep Infect Dis. 2018 Jun 5;2018:5263438. doi: 10.1155/2018/5263438. eCollection 2018.
7
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study.无症状念珠菌尿症住院患者的过度治疗：一项多机构研究。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01464-17. Print 2018 Jan.
8
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.米卡芬净的临床药代动力学和药效学。
Clin Pharmacokinet. 2018 Mar;57(3):267-286. doi: 10.1007/s40262-017-0578-5.
9
Micafungin treatment and eradication of candiduria among hospitalized patients.米卡芬净治疗并根除住院患者念珠菌尿症
Int Urol Nephrol. 2016 Nov;48(11):1881-1885. doi: 10.1007/s11255-016-1410-0. Epub 2016 Sep 1.
10
Micafungin in the treatment of candiduria: A case series.米卡芬净治疗念珠菌尿症：病例系列报道
Med Mycol Case Rep. 2016 Jan 30;11:5-8. doi: 10.1016/j.mmcr.2016.01.003. eCollection 2016 Mar.
本文引用的文献
1
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.1989 - 1999年美国重症监护病房患者医院获得性念珠菌血症的长期趋势。
Clin Infect Dis. 2002 Sep 1;35(5):627-30. doi: 10.1086/342300. Epub 2002 Aug 2.
2
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.新型脂肽抗真菌剂FK463在播散性念珠菌病和曲霉病小鼠模型中的疗效。
Antimicrob Agents Chemother. 2000 Mar;44(3):614-8. doi: 10.1128/AAC.44.3.614-618.2000.
3
Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998.1994年和1998年念珠菌属尿液分离株的抗真菌药敏趋势。
J Clin Microbiol. 2000 Feb;38(2):870-1. doi: 10.1128/JCM.38.2.870-871.2000.
4
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.住院患者真菌尿症的前瞻性多中心监测研究。美国国立过敏与传染病研究所（NIAID）真菌病研究小组。
Clin Infect Dis. 2000 Jan;30(1):14-8. doi: 10.1086/313583.
5
Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans.光滑念珠菌和白色念珠菌所致医院获得性念珠菌尿的危险因素。
Clin Infect Dis. 1999 Oct;29(4):926-8. doi: 10.1086/520460.
6
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.光滑念珠菌：与白色念珠菌相比的流行病学、发病机制及临床疾病综述
Clin Microbiol Rev. 1999 Jan;12(1):80-96. doi: 10.1128/CMR.12.1.80.
7
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.侵袭性念珠菌感染的管理：氟康唑与两性霉素B前瞻性、随机、多中心研究结果及文献综述
Clin Infect Dis. 1996 Nov;23(5):964-72. doi: 10.1093/clinids/23.5.964.
8
Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.白色念珠菌棘白菌素抗性突变体的特性分析：遗传学、生物化学及毒力研究
Infect Immun. 1996 Aug;64(8):3244-51. doi: 10.1128/iai.64.8.3244-3251.1996.
9
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.1980 - 1990年美国医院获得性真菌感染流行病学的长期趋势。国家医院感染监测系统。
J Infect Dis. 1993 May;167(5):1247-51. doi: 10.1093/infdis/167.5.1247.
10
Fluconazole resistance in Candida glabrata.光滑念珠菌对氟康唑的耐药性
Antimicrob Agents Chemother. 1993 Sep;37(9):1962-5. doi: 10.1128/AAC.37.9.1962.
Zotero 插件